UCLA Researchers & Innovators
Industry & Investors
News & Events
About
Concierge
Search Results - crispr
3
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Identification of a Factor That Rescues Dysregulated Endocytosis in Cultured Human Hematopoietic Stem Cells (UCLA Case No. 2023-051)
UCLA researchers in the Departments of Molecular, Cell & Developmental Biology have developed a novel method to enhance the function of hematopoietic stem cells (HSCs) to improve the transplantability of ex vivo expanded human HSCs in clinical settings. BACKGROUND: Hematopoietic stem cells (HSCs), present in blood and bone marrow, can form mature...
Published: 10/3/2024
|
Inventor(s):
Hanna Mikkola
,
Julia Aguade Gorgorio
Keywords(s):
bone marrow
,
bone marrow transplants
,
CRISPR
,
endocytosis
,
engraftment
,
environmental sensing
,
hematopoietic stem cells
,
leukemia
,
MLLT3
,
MYCT1
,
transplantability
Category(s):
Therapeutics > Hematology
,
Life Science Research Tools
,
Therapeutics > Stem Cells And Regenerative Medicine
Targeted Epigenetic Editing as Novel Therapy for Malignant Glioma (UCLA Case No. 2023-047)
UCLA Researchers in the Department of Neurology/Neuro-Oncology and the David Geffen School of Medicine have developed methods for the Cas9-
CRISPR
mediated epigenetic targeting of malignant glioma, and which results in enhanced chemosensitivity to standard chemotherapeutic agents. BACKGROUND: Malignant gliomas are aggressive brain tumors originating...
Published: 1/17/2024
|
Inventor(s):
Serendipity Zapanta Rinonos
,
Albert Lai
Keywords(s):
Brain
,
Cancer
,
Cancer stem cells
,
Chemotherapy
,
Combination therapy
,
CRISPR
,
CRISPR
-Cas9
,
Epigenetics
,
GBM
,
Glioma
Category(s):
Therapeutics > Oncology
,
Therapeutics > CNS and Neurology
2021-056
CRISPR
RIBONUCLEOPROTEIN COMPLEX GENOME EDITING OF HUMAN INNATE IMMUNE CELLS
Researchers in the Department of Microbiology, Immunology, and Molecular Genetics at UCLA have developed an optimized strategy for non-viral
CRISPR
-Cas9 ribonucleoprotein gene editing of primary innate immune cells. BACKGROUND:CRISPR (clustered, regularly interspaced, short palindromic repeats) genome engineering has become a powerful tool to investigate...
Published: 9/7/2023
|
Inventor(s):
Timothy O'Sullivan
,
Luke Riggan
,
Andrew Hildreth
Keywords(s):
CRISPR
,
Gene Editing Systems
Category(s):
Therapeutics > Gene Therapy And Editing